Fabry Disease
📧 Sign up to get email alerts when something new happens for Fabry Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease [Phase 2]
An open-label Phase 2 trial evaluating agalsidase alfa (Replagal) enzyme therapy in children ages 7-17 with Fabry disease; the study status …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells [Phase 1]
A Phase 1 clinical trial update on gene therapy for Gaucher disease and Fabry disease using viral vectors and blood-forming cells has comple…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Replagal Enzyme Replacement Therapy for Adults With Fabry Disease [Phase 4]
This update reports completion of a Phase 4 clinical trial evaluating Replagal enzyme replacement therapy in adults with Fabry disease.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Vasodilation in Patients With Fabry's Disease
A completed clinical trial evaluating vasodilation in Fabry disease patients. The study included participants with a history of stroke.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: PET Scans in Normal Volunteers and Patients With Fabry Disease
This trial evaluated PET imaging in healthy volunteers and patients with Fabry disease and is now completed. It was sponsored by the Nationa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Neuropathic Pain and Fabry Disease
A clinical trial investigating neuropathic pain in Fabry disease (NCT00168974) has completed, sponsored by the Danish Pain Research Center.
-
CLINICAL_TRIALS trial_result · 2007-06-18Clinical Trial Update: Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease [Phase 4]
Phase 4 trial evaluating the efficacy and safety of agalsidase beta in heterozygous females with Fabry disease.